IP Verse

Janssen Pharmaceuticals competitive analysis

Loading summary...

Latest oppositions filed by Janssen Pharmaceuticals

Explore patent oppositions filed by Janssen Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3291679	Altering Microbial Populations & Modifying Microbiota	SNIPR	Sep 14, 2022
EP2588167	Safety Device For A Pre-Filled Syringe And Injection Device	SANOFI AVENTIS DEUTSCHLAND	Nov 21, 2018

Latest patents of Janssen Pharmaceuticals opposed by its competitors

Explore Janssen Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3744326	Dec 6, 2023	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	9
EP3280416	Apr 22, 2020	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	9

Latest publications and patents of Janssen Pharmaceuticals New

Explore the latest publications and patents granted to Janssen Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Janssen Pharmaceuticals
EP3744326	Dec 6, 2023	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	Granted And Under Opposition
EP3280416	Apr 22, 2020	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	Granted And Under Opposition

Latest PTAB cases involving Janssen Pharmaceuticals

Discover the latest PTAB cases involving Janssen Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Janssen Pharmaceuticals
IPR2013-00365	Jun 19, 2013	HOSPIRA	JANSSEN PHARMACEUTICALS	Institution Denied

Peer Comparison New

IP litigation analysis comparing Janssen Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
JANSSEN PHARMACEUTICALS	2	18	-	1
ACCORD HEALTHCARE	39	-	4	-
HAMM & WITTKOPP	112	-	-	-
HOFFMANN EITLE	148	-	-	-